Read more
03 Nov 2020
PromorePharma utilize data review services to prove efficacy
Promore Pharma AB (publ) undertook an 18-site clinical trial to further prove the efficacy and safety of ropocamptide (LL-37) for patients with hard to…
Read more
20 May 2020